
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer‐associated fibroblast subtypes
Jeppe Thorlacius‐Ussing, Christina Jensen, Neel I. Nissen, et al.
The Journal of Pathology (2023) Vol. 262, Iss. 1, pp. 22-36
Open Access | Times Cited: 38
Jeppe Thorlacius‐Ussing, Christina Jensen, Neel I. Nissen, et al.
The Journal of Pathology (2023) Vol. 262, Iss. 1, pp. 22-36
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Zhongsong Zhang, Long Chen
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Zhongsong Zhang, Long Chen
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Cancer associated fibroblasts in cancer development and therapy
Hongyuan Jia, Xingmin Chen, Linling Zhang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Hongyuan Jia, Xingmin Chen, Linling Zhang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Multiple aspects of matrix stiffness in cancer progression
Alessandro Mancini, Maria Teresa Gentile, Francesca Pentimalli, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 11
Alessandro Mancini, Maria Teresa Gentile, Francesca Pentimalli, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 11
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 10
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 10
NetSDR: Drug repurposing for cancers based on subtype-specific network modularization and perturbation analysis
Bin Yang, Wanshi Li, Zhen Xu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167688-167688
Closed Access | Times Cited: 1
Bin Yang, Wanshi Li, Zhen Xu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167688-167688
Closed Access | Times Cited: 1
Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8+ T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine-learning bioinformatics retrospective study
Jingxian Li, Ning Kong, Yuanjiong Qi, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 7
Jingxian Li, Ning Kong, Yuanjiong Qi, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 7
CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy
Keishi Yamashita, Yusuke Kumamoto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6003-6003
Open Access | Times Cited: 7
Keishi Yamashita, Yusuke Kumamoto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6003-6003
Open Access | Times Cited: 7
Metabolic control of collagen synthesis
Julien Guillard, Simon Schwörer
Matrix Biology (2024) Vol. 133, pp. 43-56
Closed Access | Times Cited: 5
Julien Guillard, Simon Schwörer
Matrix Biology (2024) Vol. 133, pp. 43-56
Closed Access | Times Cited: 5
Circular RNAs as Key Regulators in Cancer Hallmarks: New Progress and Therapeutic Opportunities
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Rohana Jaafar, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104612-104612
Open Access
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Rohana Jaafar, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104612-104612
Open Access
Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses
Geofrey F. Soko, Benson Kiprono Kosgei, Stephene S. Meena, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Geofrey F. Soko, Benson Kiprono Kosgei, Stephene S. Meena, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
The Dynamic Changes of COL11A1 Expression During the Carcinogenesis and Development of Breast Cancer and as a Candidate Diagnostic and Prognostic Marker
Yuli Wang, Jing Wang
The Breast Journal (2025) Vol. 2025, Iss. 1
Open Access
Yuli Wang, Jing Wang
The Breast Journal (2025) Vol. 2025, Iss. 1
Open Access
Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer
Xun‐Xi Lu, Zongchao Gou, Hong Chen, et al.
The Journal of Pathology (2025)
Closed Access
Xun‐Xi Lu, Zongchao Gou, Hong Chen, et al.
The Journal of Pathology (2025)
Closed Access
Collagen turnover biomarkers to predict outcome of patients with biliary cancer
Leonard Kaps, Muhammed A. Genc, Markus Moehler, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Leonard Kaps, Muhammed A. Genc, Markus Moehler, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
The METTL3/TGF-β1 signaling axis promotes osteosarcoma progression by inducing MSC differentiation into CAFs via m6A modification
Jin Qi, Sihang Liu, Ben-quan Wu, et al.
Journal of bone oncology (2025) Vol. 51, pp. 100662-100662
Open Access
Jin Qi, Sihang Liu, Ben-quan Wu, et al.
Journal of bone oncology (2025) Vol. 51, pp. 100662-100662
Open Access
Aberrant expression of collagen type X in solid tumor stroma is associated with EMT, immunosuppressive and pro-metastatic pathways, bone marrow stromal cell signatures, and poor survival prognosis
Elliot H. H. Youth, Aryana Javaheri, Dongfang Yang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Elliot H. H. Youth, Aryana Javaheri, Dongfang Yang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway
Longhai Li, Zhaoshuai Ji, Guangyun Li, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318776-e0318776
Open Access
Longhai Li, Zhaoshuai Ji, Guangyun Li, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318776-e0318776
Open Access
Cancer‐Associated Fibroblast Signature Can Predict Prognosis and Therapeutic Responses in Skin Cutaneous Melanoma
Yue Zheng, Weihuan Shao, Tongxin Ge, et al.
Pigment Cell & Melanoma Research (2025) Vol. 38, Iss. 2
Closed Access
Yue Zheng, Weihuan Shao, Tongxin Ge, et al.
Pigment Cell & Melanoma Research (2025) Vol. 38, Iss. 2
Closed Access
The role of various collagen types in tumor biology: a review
Yuchuan Zhou, Zhonghui Jiang, Lu Cao, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Yuchuan Zhou, Zhonghui Jiang, Lu Cao, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics
M.A. Karsdal, Thomas R. Cox, Amelia L. Parker, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1856-1856
Open Access
M.A. Karsdal, Thomas R. Cox, Amelia L. Parker, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1856-1856
Open Access
Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights
Zhongsong Zhang, Yujie Tang, Dan Luo, et al.
APL Bioengineering (2025) Vol. 9, Iss. 1
Open Access
Zhongsong Zhang, Yujie Tang, Dan Luo, et al.
APL Bioengineering (2025) Vol. 9, Iss. 1
Open Access
Integrative bioinformatics analysis of high-throughput sequencing and in vitro functional analysis leads to uncovering key hub genes in esophageal squamous cell carcinoma
Feng Shen, Xing Liu, Fengjiao Ding, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Feng Shen, Xing Liu, Fengjiao Ding, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Molecular biology of the deadliest cancer – glioblastoma: what do we know?
A Kh Ismaĭlov, Aldo Spallone, Alexey A. Belogurov, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A Kh Ismaĭlov, Aldo Spallone, Alexey A. Belogurov, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Differential Protease Specificity by Collagenase as a Novel Approach to Serum Proteomics That Includes Identification of Extracellular Matrix Proteins without Enrichment
Jade K. Macdonald, Cassandra L. Clift, Janet Saunders, et al.
Journal of the American Society for Mass Spectrometry (2024) Vol. 35, Iss. 3, pp. 487-497
Open Access | Times Cited: 3
Jade K. Macdonald, Cassandra L. Clift, Janet Saunders, et al.
Journal of the American Society for Mass Spectrometry (2024) Vol. 35, Iss. 3, pp. 487-497
Open Access | Times Cited: 3
The fibro-adipogenic progenitor APOD+DCN+LUM+ cell population in aggressive carcinomas
Lingyi Cai, Mikhail G. Kolonin, Dimitris Anastassiou
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 977-980
Open Access | Times Cited: 3
Lingyi Cai, Mikhail G. Kolonin, Dimitris Anastassiou
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 977-980
Open Access | Times Cited: 3
Oncogenic mechanisms of COL10A1 in cancer and clinical challenges (Review)
Qiang Yi, Gangfeng Zhu, Weijian Zhu, et al.
Oncology Reports (2024) Vol. 52, Iss. 6
Open Access | Times Cited: 3
Qiang Yi, Gangfeng Zhu, Weijian Zhu, et al.
Oncology Reports (2024) Vol. 52, Iss. 6
Open Access | Times Cited: 3